Knockdown of PEX16 Induces Autophagic Degradation of Peroxisomes.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Jul 2021
Historique:
received: 06 06 2021
revised: 16 07 2021
accepted: 23 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 9 9 2021
Statut: epublish

Résumé

Peroxisome abundance is regulated by homeostasis between the peroxisomal biogenesis and degradation processes. Peroxin 16 (PEX16) is a peroxisomal protein involved in trafficking membrane proteins for de novo peroxisome biogenesis. The present study demonstrates that PEX16 also modulates peroxisome abundance through pexophagic degradation. PEX16 knockdown in human retinal pigment epithelial-1 cells decreased peroxisome abundance and function, represented by reductions in the expression of peroxisome membrane protein ABCD3 and the levels of cholesterol and plasmalogens, respectively. The activation of pexophagy under PEX16 knockdown was shown by (i) abrogated peroxisome loss under PEX16 knockdown in autophagy-deficient ATG5 knockout cell lines, and (ii) increased autophagy flux and co-localization of p62-an autophagy adaptor protein-with ABCD3 in the presence of the autophagy inhibitor chloroquine. However, the levels of cholesterol and plasmalogens did not recover despite the restoration of peroxisome abundance following chloroquine treatment. Thus, PEX16 is indispensable for maintaining peroxisome homeostasis by regulating not only the commonly known biogenesis pathway but also the autophagic degradation of peroxisomes.

Identifiants

pubmed: 34360754
pii: ijms22157989
doi: 10.3390/ijms22157989
pmc: PMC8348608
pii:
doi:

Substances chimiques

ABCD3 protein, human 0
ATG5 protein, human 0
ATP-Binding Cassette Transporters 0
Autophagy-Related Protein 5 0
Membrane Proteins 0
PEX16 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea (NRF)
ID : 2019R1A2C2086080
Organisme : National Research Foundation of Korea (NRF)
ID : 2018R1A5A1024340

Références

Nat Cell Biol. 2015 Oct;17(10):1259-1269
pubmed: 26344566
J Cell Sci. 2013 Feb 15;126(Pt 4):939-52
pubmed: 23239026
Biochim Biophys Acta. 2006 Dec;1763(12):1733-48
pubmed: 17055079
Cell Metab. 2014 Mar 4;19(3):380-92
pubmed: 24508507
Biochem Biophys Res Commun. 2020 Feb 16;:
pubmed: 32075719
PLoS One. 2012;7(4):e35490
pubmed: 22536392
Int J Mol Sci. 2020 Jan 16;21(2):
pubmed: 31963200
Exp Cell Res. 2008 Nov 15;314(19):3531-41
pubmed: 18848543
Nature. 2017 Feb 9;542(7640):251-254
pubmed: 28146471
Nat Rev Mol Cell Biol. 2013 Dec;14(12):803-17
pubmed: 24263361
Cell Death Differ. 2017 Jul;24(7):1148-1152
pubmed: 28409773
Mol Cell Biol. 2004 Jan;24(1):1-13
pubmed: 14673138
Mol Genet Metab. 2003 Nov;80(3):290-5
pubmed: 14680974
EMBO Rep. 2019 Jan;20(1):
pubmed: 30530632
Trends Cell Biol. 2004 Sep;14(9):515-23
pubmed: 15350980
J Cell Biol. 2009 Oct 19;187(2):265-77
pubmed: 19822672
Histochem Cell Biol. 2013 Oct;140(4):423-42
pubmed: 23959168
J Mol Biol. 2015 Mar 27;427(6 Pt A):1176-90
pubmed: 25681696
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Mar;1862(3):358-368
pubmed: 28017862
Biochim Biophys Acta. 2012 Sep;1822(9):1442-52
pubmed: 22627108
Biochim Biophys Acta. 2016 May;1863(5):971-83
pubmed: 26409486
J Cell Biol. 2004 Jan 5;164(1):57-67
pubmed: 14709540
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20567-74
pubmed: 19074260
Autophagy. 2017 May 4;13(5):868-884
pubmed: 28521612
Mol Cell Biol. 2010 Dec;30(24):5672-85
pubmed: 20937771
Trends Biochem Sci. 2021 Mar;46(3):200-212
pubmed: 33046344
J Cell Biol. 2008 Dec 29;183(7):1275-86
pubmed: 19114594
J Lipid Res. 2010 Oct;51(10):2863-95
pubmed: 20558530
Biochimie. 2014 Mar;98:75-85
pubmed: 24211592
Cell Metab. 2014 Nov 4;20(5):882-897
pubmed: 25440060
Biochim Biophys Acta. 2016 May;1863(5):984-91
pubmed: 26434997
Autophagy. 2014 Sep;10(9):1549-64
pubmed: 25007327

Auteurs

Xiaofan Wei (X)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Yunash Maharjan (Y)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Debra Dorotea (D)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Raghbendra-Kumar Dutta (RK)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Donghyun Kim (D)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Hyunsoo Kim (H)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Yizhu Mu (Y)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Channy Park (C)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Raekil Park (R)

Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH